• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.36 número5

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.36 número5" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.36 número5".

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Comitê de Doenc¸as Infecciosas Transmitidas por Transfusão, Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular, Rio de Janeiro, RJ, Brazil.. The number of cases of Chik[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Conclusion: These results confirm the high frequency of BCR-ABL rearrangements and the low survival rate of adult Brazilian patients with acute lymphoblastic leukemia7. © 2014 Associac¸ã[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... A total of 51 SCD patients were enrolled in this study: 36 (70.6%) with sickle cell anemia (SCA) or Hb SS and 15 (29.4%) with Hb SC disease. Overall, the mean age of the patients was 11.76 ± 3.69 years. The Hb SS ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Detection of cytogenetic abnormalities in mature B-cell neoplasms: the value of cultures with.. different mitogens.[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... After measuring enzyme levels and genotyping, all five patients affected by the disease in this family fall into the clinical classification of type 1 GD.. In the International Collabora[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... ease, and a second related donor allogeneic hematopoietic stem cell transplantation.. was performed.[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Acute renal failure following allogeneic hematopoietic cell transplantation: incidence, outcome and risk factors. Saudi J Kidney Dis Transpl[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... that the majority of oncological clinics located in areas with endemic L. chagasi infections continue to have difficulties in making a firm diagnosis of VL. The clinical manifestations o[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Eight-year clinical outcomes of long-term enzyme replacement therapy for 884 children with Gaucher Disease Type 1. Siebert M, Bock H, Michelin-Tirelli K, Coelho JC, Giugliani R, Saraiva-[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... This study shows that despite the medical advances in recent decades, pregnancy is still associated with many clinical and obstetric complications in patients with SCD, resulting in a hi[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... In SCD patients, increased mean cell volume and low fetal hemoglobin were reported in both genders and high total hemoglobin and high mean corpuscular hemoglobin concentration were obser[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... e Hemoter- apia, Camilo-Araújo present an analysis of the frequency of ␤S-globin haplotypes and alpha-thalassemia, and their influ- ence on clinical manifestations and the hematological profile of children with ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... Although increasing knowledge on the complex pathophysiology of the sickle vaso-occlusive process has enabled better characterization of the endothelial dysfunction in SCD and how differ[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... was the relationship between megakaryocyte TGF ␤ 1 expression, MVD and bone marrow fibrosis, suggesting a possible mechanism by which increased levels of TGF ␤ 1 produced by megakaryocyt[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.36 número5

Rev. Bras. Hematol. Hemoter. vol.36 número5

... In the article “Are the review criteria for automated complete blood counts of the International Society of Laboratory Hemato- logy suitable for all hematology laboratories?”, published [r] ... See full document

1

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... Two deaths (28.6%) occurred in patients with suspected primary hemophagocytic lymphohistiocytosis; one whose clinical picture was triggered by cytomegalovirus infection did not respond t[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... Mutations that reflect defects in the Klotho gene expression may be implicated in the onset of osteonecrosis, pri- apism, and leg ulcers in patients with sickle cell disease, as a result[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... Objective: The purpose of this study was to evaluate the effectiveness of mature red cell and reticulocyte parameters under three conditions: iron deficiency anemia, anemia of chronic di[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... The frequency of acute toxicity related to HSCT, in this con- text represented by GI symptoms, was high however the high aggressiveness of allogeneic transplantation should be con- sidered. In this study, over 90% of the ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.36 número6

Rev. Bras. Hematol. Hemoter. vol.36 número6

... The aim of the study was to evaluate the intestinal barrier function in leukemic patients prior to chemotherapy, by test- ing intestinal permeability by the determination of urinary lact[r] ... See full document

5

Show all 10000 documents...